Cabot (CBT) Tops Q2 Earnings Estimates
Cabot (CBT) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $1.78 per share a year ago.
Cabot (CBT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Cabot (CBT) Down 7.9% Since Last Earnings Report?
Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
Cabot Corporation: Reinforcing Positive Shareholder Value
Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value.
Cabot Corporation (CBT) Q1 2025 Earnings Call Transcript
Cabot Corporation (NYSE:CBT ) Q1 2025 Earnings Conference Call January 30, 2025 8:00 AM ET Company Participants Sean Keohane - President & CEO Erica McLaughlin - EVP & CFO Steve Delahunt - VP, Treasurer & IR Conference Call Participants Chris Perrella - UBS John Roberts - Mizuho Group David Begleiter - Deutsche Bank Kevin Estok - Jefferies Lydia Huang - J.P. Morgan Operator Good day.
Cabot's Earnings and Revenues Lag Estimates in Q1, EPS Up Y/Y
Cabot misses Q1 earnings and revenue estimates but demonstrates better results in EBIT and adjusted EPS metrics.
Cabot (CBT) Q1 Earnings and Revenues Miss Estimates
Cabot (CBT) came out with quarterly earnings of $1.76 per share, missing the Zacks Consensus Estimate of $1.80 per share. This compares to earnings of $1.56 per share a year ago.
Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)
Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth.
Cabot (CBT) Earnings Expected to Grow: Should You Buy?
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot (CBT) Up 1.6% Since Last Earnings Report: Can It Continue?
Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
Cabot Increases Share Repurchase Authorization by 10 Million
All repurchased shares of CBT will be retired and restored to the status of authorized but unissued common stock of the company.
Encore Capital Q3 Earnings Miss Estimates on Lower Purchases by Cabot
ECPG's third-quarter earnings suffer from rising operating expenses and the competitive environment in the U.K. Improved portfolio purchasing in the United States partially offset the negatives.
